Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of CBT-001 ophthalmic emulsion in pterygium
CTR20232598Phase 3Active
- Sponsor
- Cloudbreak Pharma
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nintedanib in pterygium, sponsored by Cloudbreak Pharma. Started Mar 2024; status: active.
02
Drugs
nintedanib
03
Conditions
pterygium
Beyond the preview
Go deeper on CTR20232598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232598.